Pharmaceutical Industry Reports
Telmisartan Market Size, Share, Outlook, and Analy
Telmisartan was approved for use in the U.S., for treatment of hypertension in 1998. Telmisartan is available in 20, 40 and 80 mg tablets in generic forms and under the trade name, Micardis.
Nanobodies are considered to be one of the best technology in the fields of research, diagnostics and therapy especially in cancer research.